bucladesine has been researched along with B-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, BA; Negrin, RS; Schmidt-Wolf, IG; Weissman, IL | 1 |
| Alaverdi, N; Linsley, PS; Wade, WF; Watts, TH | 1 |
| Brown, DM; Phipps, RP | 1 |
3 other study(ies) available for bucladesine and B-Cell Lymphoma
| Article | Year |
|---|---|
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.
Topics: Biomarkers; Bucladesine; CD3 Complex; CD56 Antigen; Cell Line, Transformed; Cyclic AMP; Cyclosporine; Cytokines; Cytoplasmic Granules; Cytotoxicity, Immunologic; Exocytosis; Granzymes; Humans; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Subsets; Lymphoma, B-Cell; Muromonab-CD3; Neoplasm Proteins; Serine Endopeptidases; Signal Transduction; Tacrolimus; Tumor Cells, Cultured | 1995 |
Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction.
Topics: Antigens, Surface; B7-1 Antigen; Bucladesine; Cell Communication; Cell Line; Cell-Free System; Cholera Toxin; GTP-Binding Proteins; Histocompatibility Antigens Class II; Humans; Lymphocyte Activation; Lymphoma, B-Cell; T-Lymphocytes; Tumor Cells, Cultured | 1993 |
Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
Topics: Apoptosis; B-Lymphocytes; Bucladesine; Cell Cycle; Dinoprostone; DNA Damage; DNA, Neoplasm; Drug Resistance; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogenes; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 1996 |